Hepta Bio
Biotechnology company developing non-invasive diagnostic tests for liver disease, aiming to replace liver biopsies with blood-based testing for conditions like NASH and fibrosis.
Website
https://www.heptabio.comLocation
Boston, Massachusetts, USA
Founded
2020
Investors
1
Categories
diagnostics, liver-disease, non-invasive, biotech, biomarkers
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |
